The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00770588
Brief Title: Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC) (INFORM)

First Submitted : October 9, 2008
First Submitted that Met QC Criteria : October 9, 2008
First Posted : October 10, 2008 (Estimate)

Results First Submitted : January 17, 2012
Results First Submitted that Met QC Criteria : July 11, 2012
Results First Posted : August 20, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 15, 2016
Last Update Posted : February 8, 2016 (Estimate)